PSI
MYGN icon

Pinnacle Summer Investments’s Myriad Genetics MYGN Stock Holding History

Pinnacle Summer Investments’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-18
Closed -$18K – 1016
2014
Q4 		$18K Sell
18
-557
-97% -$19.8K ﹤0.01% 688
2014
Q3 		$22K Buy
575
+246
+75% +$9.18K ﹤0.01% 661
2014
Q2 		$13K Buy
329
+125
+61% +$4.65K ﹤0.01% 729
2014
Q1 		$7K Buy
204
+149
+271% +$4.62K ﹤0.01% 755
2013
Q4 		$1K Hold
55
– – ﹤0.01% 930
2013
Q3 		$1K Buy
+55
New +$1.56K ﹤0.01% 905

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Pinnacle Summer Investments's MYGN Position: Q1 2015 in Review

Pinnacle Summer Investments sold out of Myriad Genetics (MYGN) in Q1 2015, closing a stake of 18 shares — an estimated $18K sold.

Pinnacle Summer Investments first reported a position in MYGN in Q3 2013 and held it in 6 quarters. The position peaked at $22K in Q3 2014. 251 funds tracked by Wall St. Rank hold MYGN as of Q1 2015.

  • Pinnacle Summer Investments reported no remaining Myriad Genetics position as of Q1 2015 after selling out during the quarter.
  • Pinnacle Summer Investments sold 18 Myriad Genetics shares in Q1 2015, an estimated $18K.
  • Pinnacle Summer Investments first reported a position in Myriad Genetics in Q3 2013 and held it in 6 quarters.
  • Pinnacle Summer Investments's Myriad Genetics position peaked at $22K in Q3 2014.
  • 251 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2015.

Based on Pinnacle Summer Investments's 13F filing for Q1 2015, filed 19 May 2015.